Latest Epidermal growth factor receptor Stories
GENEVA, April 17, 2015 /PRNewswire/ -- ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable alternative
Non-invasive liquid biopsy enables detection of emerging T790M mutations with greater sensitivity than tissue biopsy and months before detection of cancer progression with imaging
DALLAS, March 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Lonsurf and Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 research report focuses on
Research Presented at 2015 Genitourinary Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence in Identifying Potential Treatment Strategies for Challenging Genitourinary Cancers
Research Presented at 2015 Gastrointestinal Cancers Symposium Highlights Clinical Utility of Caris Molecular Intelligence IRVING, Texas, Jan.
- Results from two large trials individually showed an improvement in the secondary endpoint of overall survival for patients with the most common EGFR mutation (Del19) RIDGEFIELD, Conn., Jan.
HILDEN, Germany, January 12, 2015 /PRNewswire/ -- - QIAGEN's circulating tumor DNA test is now CE-IVD marked to assess EGFR mutation status in
RnRMarketResearch.com adds “Erbitux (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.
Researchers report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining the intestines of mice, triggering a reaction that ultimately reduces the risk of colorectal tumors.
HILDEN, Germany and LONDON, July 28, 2014 /PRNewswire/ -- - Collaboration aims to create and commercialize companion diagnostic using genomic data
- a study of the individuals in a group of people within a specific context and their relationships.
- In rhetoric, the description of any one's personal appearance.